跳到內容

血液科

再生障礙性(不良性)貧血

Eltrombopag added to immunosuppression in severe aplastic anemia. (開啟新視窗)

Peffault de Latour R, Kulasekararaj A, Iacobelli S, Terwel SR, Cook R, Griffin M, Halkes CJM, Recher C, Barraco F, Forcade E, Vallejo JC, Drexler B, Mear JB, Smith AE, Angelucci E, Raymakers RAP, de Groot MR, Daguindau E, Nur E, Barcellini W, Russell NH, Terriou L, Iori AP, La Rocca U, Sureda A, Sánchez-Ortega I, Xicoy B, Jarque I, Cavenagh J, Sicre de Fontbrune F, Marotta S, Munir T, Tjon JML, Tavitian S, Praire A, Clement L, Rabian F, Marano L, Hill A, Palmisani E, Muus P, Cacace F, Frieri C, van Lint MT, Passweg JR, Marsh JCW, Socié G, Mufti GJ, Dufour C, Risitano AM; Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation

來源‎: N Engl J Med 2022;386(1):11-23.

檢索‎: PubMed 34986284

DOI碼‎: 10.1056/NEJMoa2109965

https://pubmed.ncbi.nlm.nih.gov/34986284/ (開啟新視窗)

Eltrombopag added to standard immunosuppression for aplastic anemia. (開啟新視窗)

Townsley DM, Scheinberg P, Winkler T, Desmond R, Dumitriu B, Rios O, Weinstein B, Valdez J, Lotter J, Feng X, Desierto M, Leuva H, Bevans M, Wu C, Larochelle A, Calvo KR, Dunbar CE, Young NS

來源‎: N Engl J Med 2017;376(16):1540-50.

檢索‎: PubMed 28423296

DOI碼‎: 10.1056/NEJMoa1613878

https://www.ncbi.nlm.nih.gov/pubmed/28423296 (開啟新視窗)